Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-005824
Filing Date
2024-11-14
Accepted
2024-11-14 12:24:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 KYNAM CAPITAL MANAGEMENT, LP cogta1_111424.htm SC 13G/A 42661
  Complete submission text file 0001085146-24-005824.txt   44401
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90431 | Film No.: 241459348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 221 ELM ROAD PRINCETON NJ 08540
Business Address 221 ELM ROAD PRINCETON NJ 08540 212-659-3970
Kynam Capital Management, LP (Filed by) CIK: 0001907884 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A